These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6985196)

  • 1. [Effects of levamisole on methylcholanthrene-induced tumor. II. Potentiation of cytotoxic T-cell activities].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1269-76. PubMed ID: 6985196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
    Tanida S; Uchida H; Taniguchi K; Nomoto K
    Cancer Res; 1989 Jan; 49(2):284-8. PubMed ID: 2783379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and characterization of anti-tumour effector cells in Meth-A-bearing mice treated with recombinant human interleukin 2.
    Naruo KI; Hinuma S; Shiho O; Houkan T; Ootsu K; Tsukamoto K
    Clin Exp Immunol; 1989 May; 76(2):278-83. PubMed ID: 2788049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imuthiol influences on cytotoxic T cells and NK activity in +/+ and athymic nude BALB/c mice.
    Florentin I; Chung V; Renoux M; Renoux G
    Immunopharmacol Immunotoxicol; 1989; 11(4):645-55. PubMed ID: 2560786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural cytostatic cells have a broader range of antitumor activity than natural killer cells.
    Kato M; Kawauchi H; Taniguchi K; Katsuki T; Nomoto K
    J Clin Lab Immunol; 1985 Jan; 16(1):47-51. PubMed ID: 3872372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
    J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of levamisole on the cytotoxic activity of normal lymphocytes in tissue culture].
    Chumakova MM; Kadagidze ZG
    Biull Eksp Biol Med; 1979 Nov; 88(11):581-2. PubMed ID: 540153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytotoxic cell activities by a novel cyclic disulfide compound, SA3443 in vivo.
    Sasano M; Tanaka M; Nakata K; Mita S
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):121-33. PubMed ID: 1770215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
    No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.